Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Stübiger

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Klinische Monatsblatter Fur Augenheilkunde|April 29, 2014
[Posterior uveitis. Part 1: diagnostics and basic concepts of therapy]A Heiligenhaus, M Breitbach, G Spital, et al.
Clinical and Experimental Rheumatology|November 9, 2005
Cytokines, cytokine antagonists and soluble adhesion molecules in patients with ocular Behçet's disease treated with human recombinant interferon-alpha2a. Results of an open study and review of the literatureI Kötter, S Koch, R Vonthein, et al.
Annals of the Rheumatic Diseases|December 15, 2000
HHV8 associated Kaposi's sarcoma during triple immunosuppressive treatment with cyclosporin A, azathioprine, and prednisolone for ocular Behçet's disease and complete remission of both disorders with interferon alphaI Kötter, C Aepinus, F Graepler, et al.
The British Journal of Ophthalmology|September 20, 2005
Interferon as a treatment for uveitis associated with multiple sclerosisM D Becker, A Heiligenhaus, T Hudde, et al.
Rheumatology (Oxford, England)|July 15, 2004
Influence of human recombinant interferon-alpha2a (rhIFN-alpha2a) on altered lymphocyte subpopulations and monocytes in Behcet's diseaseM Treusch, R Vonthein, M Baur, et al.
The British Journal of Ophthalmology|March 19, 2003
Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitisI Kötter, M Zierhut, A K Eckstein, et al.
Tissue Antigens|November 13, 2001
Comparative analysis of the association of HLA-B*51 suballeles with Behçet's disease in patients of German and Turkish originI Kötter, I Günaydin, N Stübiger, et al.
Annals of the Rheumatic Diseases|February 5, 2008
EULAR recommendations for the management of Behçet diseaseG Hatemi, A Silman, D Bang, et al.
Annals of the Rheumatic Diseases|April 19, 2008
Management of Behçet disease: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for the management of Behçet diseaseG Hatemi, A Silman, D Bang, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Klinische Monatsblatter Fur Augenheilkunde|April 29, 2014
[Posterior uveitis. Part 1: diagnostics and basic concepts of therapy]A Heiligenhaus, M Breitbach, G Spital, et al.
Clinical and Experimental Rheumatology|November 9, 2005
Cytokines, cytokine antagonists and soluble adhesion molecules in patients with ocular Behçet's disease treated with human recombinant interferon-alpha2a. Results of an open study and review of the literatureI Kötter, S Koch, R Vonthein, et al.
Annals of the Rheumatic Diseases|December 15, 2000
HHV8 associated Kaposi's sarcoma during triple immunosuppressive treatment with cyclosporin A, azathioprine, and prednisolone for ocular Behçet's disease and complete remission of both disorders with interferon alphaI Kötter, C Aepinus, F Graepler, et al.
The British Journal of Ophthalmology|September 20, 2005
Interferon as a treatment for uveitis associated with multiple sclerosisM D Becker, A Heiligenhaus, T Hudde, et al.
Rheumatology (Oxford, England)|July 15, 2004
Influence of human recombinant interferon-alpha2a (rhIFN-alpha2a) on altered lymphocyte subpopulations and monocytes in Behcet's diseaseM Treusch, R Vonthein, M Baur, et al.
The British Journal of Ophthalmology|March 19, 2003
Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitisI Kötter, M Zierhut, A K Eckstein, et al.
Tissue Antigens|November 13, 2001
Comparative analysis of the association of HLA-B*51 suballeles with Behçet's disease in patients of German and Turkish originI Kötter, I Günaydin, N Stübiger, et al.
Annals of the Rheumatic Diseases|February 5, 2008
EULAR recommendations for the management of Behçet diseaseG Hatemi, A Silman, D Bang, et al.
Annals of the Rheumatic Diseases|April 19, 2008
Management of Behçet disease: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for the management of Behçet diseaseG Hatemi, A Silman, D Bang, et al.
Pageof 5